Hypothesis

Hormetic interventions that raise reactive oxygen species (ROS) above a specific threshold transiently activate the lysosomal deglycase fructosamine‑3‑kinase (FN3K), which can hydrolyze glucosepane crosslinks on long‑lived matrix proteins. Below this threshold, hormesis only triggers compensatory pathways (e.g., MMP/TIMP rebalancing) that improve function without removing the underlying glycation damage. Thus, the ability of a stressor to reverse aging‑related ECM stiffening depends on whether it pushes ROS past the FN3K activation point, not on its general hormetic strength.

Mechanistic Basis

Glucosepane forms non‑enzymatically on collagen and elastin and is resistant to proteolytic turnover (6). Recent work shows that FN3K, best known for reversing fructosamine adducts on cytosolic proteins, can also act on extracellular glycation products when delivered to lysosomes via chaperone‑mediated autophagy (2). FN3K activity is highly sensitive to ROS; oxidative modification of its catalytic cysteine increases Vmax ten‑fold at H2O2 concentrations of ~50 µM, a level reached during intense exercise or intermittent hypoxia but not during low‑intensity walking (5). Therefore, hormetic regimens that produce brief ROS spikes above this threshold could transiently boost FN3K‑mediated glucosepane clearance, while chronic low‑grade stress merely upregulates MMPs and TIMPs, mimicking a younger proteolytic profile without altering crosslink density (1,3). This explains why functional improvements (e.g., better diastolic uncoupling) can coexist with persistent AGE accumulation.

Predictions

1. In aged mice, a single bout of high‑intensity interval training (HIIT) that raises plasma ROS to >50 µM will reduce collagen‑bound glucosepane by ≥15 % within 24 h, whereas matched‑volume moderate‑intensity training will not change glucosepane despite normalizing MMP‑2/MMP‑7 levels.
2. Pharmacological inhibition of FN3K (e.g., with 5‑fluoro‑fructosamine) will abolish the glucosepane‑lowering effect of HIIT without affecting its impact on MMP/TIMP ratios.
3. Overexpression of a ROS‑insensitive FN3K mutant (Cys→Ser) in fibroblasts will prevent glucosepane removal even when cells are exposed to supra‑threshold ROS, confirming the redox switch.

Experimental Design

• Animals: 24‑month‑old C57BL/6 mice, n=10 per group.
• Interventions: (a) HIIT on treadmill (6 × 2 min at 20 m/min, 90 % VO2max); (b) moderate‑intensity continuous exercise (30 min at 10 m/min); (c) sedentary control.
• Readouts: Plasma and tissue ROS (Amplex Red assay), FN3K activity in lysosomal extracts (fluorogenic fructosamine probe), collagen‑bound glucosepane (LC‑MS/MS after acid hydrolysis), MMP‑2/MMP‑7 activity (gelatin zymography), diastolic function (echocardiography).
• Pharmacology: Subset receives FN3K inhibitor intraperitoneally 30 min before HIIT.
• Statistical test: Two‑way ANOVA with factors exercise type and inhibitor; post‑hoc Tukey. Falsification occurs if HIIT fails to lower glucosepane above baseline or if FN3K inhibition does not block this effect while still altering MMP/TIMP.

If the data support the predictions, hormesis would be reframed as a redox‑sensing switch that can, under sufficient oxidative threat, engage a genuine repair pathway for glucosepane; otherwise, hormesis remains purely compensatory.